(UVXY) ProShares Ultra VIX - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US74347Y8396 • Trading--Miscellaneous
UVXY: Futures, Options, Volatility, Derivatives, Trading, Contracts
The ProShares Ultra VIX Short-Term Futures ETF (BATS:UVXY) is designed to provide leveraged exposure to the expected volatility of the S&P 500 over the next 30 days. The ETF seeks to achieve this by tracking the performance of a portfolio of VIX futures contracts, offering 2x daily leveraged returns. As a trading tool, UVXY is tailored for short-term strategies, given its daily reset mechanism, which can lead to compounding effects that may diverge from the broader market trends over extended periods. The ETF is part of the ProShares family, known for its leveraged and inverse products, and is listed on the BATS exchange, offering high liquidity with an average daily volume of over 22 million shares. The funds AUM stands at $564.15 million, reflecting its popularity among traders seeking to capitalize on market volatility.
Technically, UVXY is currently trading at $20.82, below its 200-day SMA of $23.81, indicating a bearish trend. The 20-day SMA of $18.78 and 50-day SMA of $19.73 suggest recent upward momentum but at levels below the longer-term average. Support levels are identified at $19.4, while resistance stands at $23.7, $25.9, and $30.0. The ATR of 1.50 signals moderate volatility. Over the next three months, UVXYs performance will likely hinge on broader market conditions. If equity markets experience increased instability, UVXY could rally as investors seek protection. Conversely, a period of sustained calm may lead to a decline in the ETFs price. The technical setup suggests that a break above $23.7 could signal a bullish reversal, while a drop below $19.4 may indicate further downside.
Additional Sources for UVXY ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UVXY ETF Overview
Market Cap in USD | 197m |
Category | Trading--Miscellaneous |
TER | 0.95% |
IPO / Inception | 2011-10-03 |
UVXY ETF Ratings
Growth 5y | -93.8% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -37.9 |
Analysts | - |
Fair Price Momentum | 6.87 USD |
Fair Price DCF | - |
UVXY Dividends
No Dividends PaidUVXY Growth Ratios
Growth Correlation 3m | 21.4% |
Growth Correlation 12m | -68% |
Growth Correlation 5y | -99.3% |
CAGR 5y | -77.14% |
CAGR/Max DD 5y | -0.77 |
Sharpe Ratio 12m | -1.36 |
Alpha | -6.82 |
Beta | -6.12 |
Volatility | 95.07% |
Current Volume | 20150.6k |
Average Volume 20d | 23980.4k |
As of March 23, 2025, the stock is trading at USD 21.56 with a total of 20,150,618 shares traded.
Over the past week, the price has changed by -9.37%, over one month by +11.13%, over three months by +6.68% and over the past year by -32.31%.
No, based on ValueRay Analyses, ProShares Ultra VIX (BATS:UVXY) is currently (March 2025) a stock to sell. It has a ValueRay Growth Rating of -93.83 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UVXY as of March 2025 is 6.87. This means that UVXY is currently overvalued and has a potential downside of -68.14%.
ProShares Ultra VIX has no consensus analysts rating.
According to ValueRays Forecast Model, UVXY ProShares Ultra VIX will be worth about 7.4 in March 2026. The stock is currently trading at 21.56. This means that the stock has a potential downside of -65.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.4 | -65.6% |